MENU
YARW Yarrow Bioscience Inc Forecast, Technical & Fundamental Analysis
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases... Show more
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I. Advisor
published Earnings
YARW is expected to report earnings to rise 1,301.87% to -3000 cents per share on March 04
Q4'26
Est.
$-30.00
Q2'26
Missed
by $1.92
The last earnings report on August 13 showed earnings per share of -214 cents, missing the estimate of -21 cents. With 182.37K shares outstanding, the current market capitalization sits at 114.77M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XYZY | 25.68 | 3.12 | +13.84% |
| YieldMax XYZ Option Income Strategy ETF (XYZY) | |||
| NUV | 8.41 | 0.10 | +1.20% |
| Nuveen Municipal Value Fund | |||
| DJUN | 50.32 | 0.42 | +0.84% |
| FT Vest U.S. Equity Deep Buffer ETF - June (DJUN) | |||
| GENT | 10.01 | 0.02 | +0.15% |
| Genter Capital Taxable Quality Intermediate ETF (GENT) | |||
| HJUN | 25.27 | N/A | N/A |
| Corgi U.S. Equities 100% Structured Buffer ETF - June Series (HJUN) | |||
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
251 Little Falls Drive
Phone
N/A
Employees
4
Web
https://www.yarrowbioscience.com